Device / Technology News

RSS

FDA responds to Delcath's request for pre-NDA meeting

Delcath Systems, Inc. announced today that the U.S. Food and Drug Administration (FDA) has responded to the Company's request made in September for a pre-New Drug Application (NDA) meeting and has scheduled a date in mid-January 2012.

27 Oct 2011

New genomic approach can trace food-borne bacteria with unprecedented accuracy

With salmonella-tainted ground turkey sickening more than 100 people and listeria-contaminated cantaloupes killing 15 this year, the ability to detect outbreaks of food-borne illness and determine their sources has become a top public health priority.

27 Oct 2011

CT scans can help detect COPD among men smokers

Among men who were current or former heavy smokers, undergoing lung cancer screening with computed tomography (CT) scanning identified a substantial proportion who had chronic obstructive pulmonary disease (COPD), suggesting that this method may be helpful as an additional tool in detecting COPD, according to a study in the October 26 issue of JAMA.

27 Oct 2011

Study reveals a possible way to reduce false alarms during early breast cancer screening

Early detection of breast cancer saves thousands of lives each year. But screening for breast cancer also produces false alarms, which can cause undue stress and costly medical bills. Now, a recent study using patient blood reveals a possible way to reduce the number of false alarms that arise during early screening. Researchers found a panel of proteins shed by breast cancer that are easily detected and can distinguish between real cancer and benign lumps.

27 Oct 2011

Computer-delivered intervention for pregnant women at risk for alcohol use

A team of researchers at Wayne State University's Parent Health Lab in the School of Medicine have received a three-year grant to develop a computer-delivered intervention for pregnant women at risk for alcohol use, which can lead to lifelong negative effects on the fetus.

27 Oct 2011

Bacterin reports results of two-year study for OsteoSponge

Bacterin International Holdings, Inc., a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, reported results of a two-year study for OsteoSponge.

27 Oct 2011

BGI, UC Davis partner to create new sequencing facility in Sacramento

The University of California, Davis, and BGI, the world's largest genomic institute, based in China, have signed a historic agreement that will change the landscape of genomic sciences in California and the Western states, and foster critical breakthroughs in the areas of food security and human, animal and environmental health.

27 Oct 2011

Simple blood test could quantify a smoker's lung toxicity and danger of heart disease

A simple blood test could someday quantify a smoker's lung toxicity and danger of heart disease, researchers at UT Southwestern Medical Center have found.

27 Oct 2011

Abzyme Therapeutics licenses SUMOpro from LifeSensors

Abzyme Therapeutics, a new biotechnology company dedicated to developing methods to generate human monoclonal antibodies for the treatment of disease, announced today that they have entered into an exclusive agreement with LifeSensors to license their proprietary protein expression platform, SUMOpro™. Enhanced protein expression is key to the evolution and development of antibodies and the LifeSensors

24 Oct 2011

Taconic and Oncodesign announce agreement to co-promote and co-develop solutions to advance oncology research

Taconic, a leading provider of life sciences solutions, and Oncodesign(R), an innovative leader in the discovery of novel anti-cancer therapies, announce today that they have entered into an agreement to co-develop and co-promote pre-clinical oncology in vivo solutions for researchers worldwide. The agreement provides researchers with improved access to a large, diverse portfolio of translational models for use in pre-clinical oncology studies, along with supporting scientific services.

24 Oct 2011

Leica Microsystems introduces complete case management solution for digital pathology at Pathology Visions

Leica Microsystems announce the launch of its clinical workflow solution for Digital Pathology at Pathology Visions 2011. Digital Image Hub Enterprise* with its powerful image management, integration and communication capabilities, in conjunction with a new high performance, intuitive client viewer, SlidePath Gateway*, combine to make this the ideal solution for clinical centers moving towards true Digital Pathology implementation. Furthermore, Leica’s Total Digital Pathology solutions now provide an implementation of the DICOM Supplement 145 standard for both slide scanning and viewing.

24 Oct 2011

Bio-Images and Medimetrics partner to deliver the next generation of smart pill technology

Bio-Images Research and Medimetrics Personalized Drug Delivery have today announced a partnership to introduce the IntelliCap to the global pharmaceutical industry as a clinical research tool. The announcement was made at the annual meeting of the American Association of Pharmaceutical Scientists, being held in Washington DC, USA, between 23 and 27 October 2011.

24 Oct 2011

Invuity's illuminated breast retractor system helps surgeons to better visualize delicate structures

Invuity, a leading developer of state-of-the-art illuminated surgical technology, today introduced its illuminated breast retractor system at the American College of Surgeons' 97th Annual Clinical Congress in San Francisco.

24 Oct 2011

Zirmed releases Patient Payment Developer Kit

ZirMed, a leading provider of revenue cycle management solutions for healthcare providers, today announced the release of the ZirMed Patient Payment Developer Kit, a new partner integration toolkit allowing provider and software vendors to seamlessly leverage ZirMed's Online Bill Pay, Virtual Terminal, and payment processing services.

24 Oct 2011

external Trigeminal Nerve Stimulation pediatric clinical trial for ADHD receives NeuroSigma funding

NeuroSigma, Inc., a Los Angeles-based medical technology company, announced today that it has signed a contract with the University of California, Los Angeles (UCLA) to fund a Phase I pediatric clinical trial to study the use of non-invasive, external Trigeminal Nerve Stimulation (TNS) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

24 Oct 2011

CompCare to distribute innovative lumbar traction DDS belt in the U.S., Canada and Puerto Rico

Comprehensive Care Corporation, which provides behavioral health, substance abuse and psychotropic pharmacy management services for managed care companies throughout the U.S., today announced that it has acquired exclusive distribution rights to an innovative patented product aimed directly at reducing depression in individuals resulting from chronic back pain.

24 Oct 2011

NCI awards Metabolomx SBIR contract to develop sensor array system for detecting lung cancer

Metabolomx, a diagnostic company focused on breath analysis for the detection of cancer, today announced the Company was awarded a Small Business Innovation Research (SBIR) contract by the National Cancer Institute (NCI). The $1.14 million combined Phase I/II Fast-Track contract will support the research and development of Metabolomx' sensor array system to detect lung cancer.

24 Oct 2011

Nexidia's Enterprise Speech Intelligence solution to be implemented at Blue Cross and Blue Shield of North Carolina

Nexidia, a leading provider of customer interaction analytics solutions for business transformation, today announced that Blue Cross and Blue Shield of North Carolina (BCBSNC) has selected Nexidia's Enterprise Speech Intelligence (ESI) solution to support the company in determining enhancements to its service center operations.

24 Oct 2011

Blood tests and cultures may not be necessary in detecting early-onset GBS in newborns

For newborn infants at risk of infection with group B streptococcal (GBS) bacteria, screening blood tests cause extra pain and anxiety—without increasing detection of early-onset GBS disease, reports a study in the October issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

24 Oct 2011

US markets for neurosurgical and neurovascular devices to grow to $240 million by 2016

According to Millennium Research Group, the global authority on medical technology market intelligence, the market for the specialized devices used for neurosurgical and neurovascular treatments will grow to $240 million by 2016, driven largely by an aging population in the United States that will suffer an increasing incidence of conditions such as stroke, cerebral aneurysms and intracranial atherosclerosis disease.

From Medtronic 24 Oct 2011

Device / Technology News

FDA responds to Delcath's request for pre-NDA meeting

New genomic approach can trace food-borne bacteria with unprecedented accuracy

CT scans can help detect COPD among men smokers

Study reveals a possible way to reduce false alarms during early breast cancer screening

Computer-delivered intervention for pregnant women at risk for alcohol use

Bacterin reports results of two-year study for OsteoSponge

BGI, UC Davis partner to create new sequencing facility in Sacramento

Simple blood test could quantify a smoker's lung toxicity and danger of heart disease

Abzyme Therapeutics licenses SUMOpro from LifeSensors

Taconic and Oncodesign announce agreement to co-promote and co-develop solutions to advance oncology research

Leica Microsystems introduces complete case management solution for digital pathology at Pathology Visions

Bio-Images and Medimetrics partner to deliver the next generation of smart pill technology

Invuity's illuminated breast retractor system helps surgeons to better visualize delicate structures

Zirmed releases Patient Payment Developer Kit

external Trigeminal Nerve Stimulation pediatric clinical trial for ADHD receives NeuroSigma funding

CompCare to distribute innovative lumbar traction DDS belt in the U.S., Canada and Puerto Rico

NCI awards Metabolomx SBIR contract to develop sensor array system for detecting lung cancer

Nexidia's Enterprise Speech Intelligence solution to be implemented at Blue Cross and Blue Shield of North Carolina

Blood tests and cultures may not be necessary in detecting early-onset GBS in newborns

US markets for neurosurgical and neurovascular devices to grow to $240 million by 2016

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News